Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00864_DB01319_nanopub.RAf1s5P_UbuhzXCe0ZP6h1FsyO7im1yu9_xmEOYZEl4CU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00864_DB01319 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00864_DB01319 label "DDI between Tacrolimus and Fosamprenavir - The protease inhibitor, Fosamprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Fosamprenavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00864_DB01319]" assertion.
- drugbank_resource:DB00864_DB01319 identifier "drugbank_resource:DB00864_DB01319" assertion.
- drugbank_resource:DB00864_DB01319 title "DDI between Tacrolimus and Fosamprenavir - The protease inhibitor, Fosamprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Fosamprenavir therapy is initiated, discontinued or altered." assertion.
- drugbank:DB00864 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00864_DB01319 assertion.
- drugbank:DB01319 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00864_DB01319 assertion.